CyberKnife® for Hepatic Metastases From Colorectal Cancer
International, Phase II Study of CyberKnife® for Hepatic Metastases From Colorectal Cancer
Sponsor: Accuray Incorporated
Terminated
Lack of enrollment
Other terminated trials from Accuray Incorporated
More terminations from Accuray Incorporated
Other Colorectal Liver Metastases trials with similar outcome
A PHASE2 clinical study on Colorectal Liver Metastases, this trial is terminated or withdrawn. The trial is conducted by Accuray Incorporated and has accumulated 6 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Accuray Incorporated
- Centre Oscar Lambret
For direct contact, visit the study record on ClinicalTrials.gov .